|
1
|
Ronson A, Tvito A, Rowe JM. Liposomal cytarabine and daunorubicin (CPX-351) for treatment of acute myeloid leukemia. Expert Opin Orphan Drugs 2017. [DOI: 10.1080/21678707.2016.1256768] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Aaron Ronson
- Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
| | - Ariella Tvito
- Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
| | - Jacob M. Rowe
- Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
- Department of Hematology and Bone Marrow Transplantation, Haifa, Israel
- Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
| |
Collapse
|
|
2
|
Affiliation(s)
- Alessandro Isidori
- a Haematology and Haematopoietic Stem Cell Transplant Center, AORMN , Pesaro , Italy
| | - Federica Loscocco
- a Haematology and Haematopoietic Stem Cell Transplant Center, AORMN , Pesaro , Italy
| | - Giuseppe Visani
- a Haematology and Haematopoietic Stem Cell Transplant Center, AORMN , Pesaro , Italy
| |
Collapse
|